Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionEverence Capital Management Inc
Latest Disclosed Ownership2,252 shares
Latest Disclosed Value $ 1,740
Everence Capital Management Inc ownership in REGN / Regeneron Pharmaceuticals, Inc.

On April 28, 2026 - Everence Capital Management Inc filed a 13F-HR form disclosing ownership of 2,252 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $1,740 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 1,762 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 27.81% during the quarter.

Everence Capital Management Inc has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F REGENERON PHARM EQTY 75886F107 2,252 490 27.81 2 0.00 0.1061
2026-02-03 2025-12-31 13F REGENERON PHARM EQTY 75886F107 1,762 407 30.04 1 0.0805
2025-10-01 2025-09-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 1,355 -1,675 -55.28 1 -100.00 0.0457
2025-07-29 2025-06-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,030 -471 -13.45 2 -50.00 0.1024
2025-04-22 2025-03-31 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,501 -330 -8.61 2 0.00 0.1510
2025-01-03 2024-12-31 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,831 90 2.41 3 -33.33 0.1773
2024-10-21 2024-09-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,741 0 0.00 4 0.00 0.2481
2024-07-03 2024-06-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,741 0 0.00 3 0.00 0.2309
2024-05-08 2024-03-31 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,741 0 0.00 4 0.00 0.2379
2024-01-30 2023-12-31 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,741 70 1.91 3 0.00 0.2344
2023-10-16 2023-09-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,671 0 0.00 3 50.00 0.2347
2023-07-14 2023-06-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,671 0 0.00 3 -33.33 0.2194
2023-04-04 2023-03-31 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,671 0 0.00 3 50.00 0.2466
2023-01-31 2022-12-31 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,671 0 0.00 3 -99.92 0.2283
2022-10-07 2022-09-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,671 570 18.38 2,529 37.97 0.2337
2022-07-26 2022-06-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,101 0 0.00 1,833 -15.37 0.1635
2022-04-11 2022-03-31 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,101 0 0.00 2,166 10.62 0.1658
2022-01-28 2021-12-31 13F REGENERON PHARMACEUTICALS EQTY 75886F107 3,101 600 23.99 1,958 29.33 0.1455
2021-10-21 2021-09-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 2,501 0 0.00 1,514 8.38 0.1243
2021-07-12 2021-06-30 13F REGENERON PHARMACEUTICALS EQTY 75886F107 2,501 0 0.00 1,397 18.09 0.1149
2021-04-06 2021-03-31 13F REGENERON PHARMACEUTICALS EQTY 75886F107 2,501 0 0.00 1,183 -2.07 0.1077
2021-02-01 2020-12-31 13F/A-1 REGENERON PHARMACEUTICALS EQTY 75886F107 2,501 260 11.60 1,208 -3.67 0.1178
2021-02-01 2020-09-30 13F/A-1 REGENERON PHARMACEUTICALS EQTY 75886F107 2,241 20 0.90 1,254 -7.86 0.1379
2020-07-09 2020-06-30 13F/A-1 REGENERON PHARMACEUTICALS EQTY 75886F107 2,221 0 0.00 1,361 25.55 0.1603
2020-07-07 2020-06-30 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 2,221 1,091
2020-07-09 2020-03-31 13F/A-2 REGENERON PHARMACEUTICALS EQTY 75886F107 2,221 0 0.00 1,084 29.98 0.1526
2020-04-27 2020-03-31 13F/A-1 REGENERON PHARMACEUTICALS ORD EQTY 75886F107 2,221 0 952 0.1525
2020-04-23 2020-03-31 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 2,221 0 834 124,450.4929
2020-01-28 2019-12-31 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 2,221 660 42.28 834 92.61 0.1245
2019-10-09 2019-09-30 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,561 0 0.00 433 -11.45 0.0702
2019-08-02 2019-06-30 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,561 0 0.00 489 -23.71 0.0808
2019-05-06 2019-03-31 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,561 -176 -10.13 641 -1.23 0.1120
2019-02-05 2018-12-31 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,737 0 0.00 649 -7.55 0.1505
2018-10-22 2018-09-30 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,737 0 0.00 702 17.20 0.1394
2018-07-26 2018-06-30 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,737 0 0.00 599 0.17 0.1266
2018-04-30 2018-03-31 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,737 0 0.00 598 -8.42 0.1323
2018-02-02 2017-12-31 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,737 0 0.00 653 -15.96 0.1432
2017-10-31 2017-09-30 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,737 510 41.56 777 28.86 0.1774
2017-08-04 2017-06-30 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,227 0 0.00 603 26.95 0.1480
2017-04-19 2017-03-31 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,227 0 0.00 475 5.56 0.1248
2017-02-07 2016-12-31 13F REGENERON PHARMACEUTICALS ORD EQTY 75886F107 1,227 -535 -30.36 450 -36.44 0.1293
2016-10-19 2016-09-30 13F Regeneron Pharmaceuticals Common 75886F107 1,762 0 0.00 708 15.12 0.2101
2016-08-01 2016-06-30 13F Regeneron Pharmaceuticals Common 75886F107 1,762 0 0.00 615 -3.15 0.1887
2016-04-21 2016-03-31 13F Regeneron Pharmaceuticals Common 75886F107 1,762 0 0.00 635 -33.65 0.1974
2016-02-02 2015-12-31 13F Regeneron Pharmaceuticals Common 75886F107 1,762 322 22.36 957 42.84 0.3101
2015-11-03 2015-09-30 13F Regeneron Pharmaceuticals Common 75886F107 1,440 0 0.00 670 -8.84 0.2312
2015-08-05 2015-06-30 13F Regeneron Pharmaceuticals Common 75886F107 1,440 0 0.00 735 23.32 0.2378
2015-04-30 2015-03-31 13F Regeneron Pharmaceuticals Common 75886F107 1,440 0 0.00 596 0.85 0.1998
2015-02-05 2014-12-31 13F Regeneron Pharmaceuticals Common 75886F107 1,440 1,440 591 0.2024
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-04-06 2021-03-31 13F REGENERON PHARMACEUTICALS EQTY Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-01-11 2020-12-31 13F REGENERON PHARMACEUTICALS EQTY Put 2,501 11.60 1,208 -3.67 n/a n/a n/a
2020-10-20 2020-09-30 13F REGENERON PHARMACEUTICALS EQTY Put 2,241 1,254 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.